A Phase II Single-Arm Clinical Trial Assessing Comprehensive Ablative Radiation Therapy With Avelumab in Unresectable and Metastatic Merkel Cell Carcinoma (CARTA)
NCT04792073 · ACTIVE NOT RECRUITING · Phase 2
ReadTheTrial indexes 2 studies for Merkel Cell Carcinoma. The most common development stage is Phase 2 (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
2 clinical trials found for Merkel Cell Carcinoma.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 2 | 100% |
There are 2 clinical trials listed for Merkel Cell Carcinoma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Merkel Cell Carcinoma trials are distributed across: Phase 2 (2).